| RAD001 Phase II Trial Results Positive In Patients With Advanced Gastric Cancer After Failure Of One Or More Prior ... (Medical News Today) |
|
|
Data released show RAD001 (also known as everolimus; proposed brand name Afinitor(R)) halted tumor growth in 55% of patients with advanced gastric cancer, a condition for which there are limited treatment options. In addition, 45% of patients in the study demonstrated some tumor shrinkage(1). |